NeoVac
Biotechnology Research • 
Suites 1 And 2 127 Olympic Avenue, Milton Park, United Kingdom • 21-50 Employees
Company overview
| Headquarters | Suites 1 And 2 127 Olympic Avenue, Milton Park, Abingdon , OX14 4SA, GB |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Key Contacts at NeoVac
Eran Eilat
Senior Advisor And Co-Founder
Jan Hendrik Egberts
Chief Executive Officer
Heinrich Haas
Chief Technology Officer
NeoVac Email Formats
NeoVac uses 2 email formats. The most common is {first name} (e.g., john@neovac.co.uk), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@neovac.co.uk | 60% |
{first initial} | j@neovac.co.uk | 40% |
About NeoVac
NeoVac is a clinical-stage company creating a revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines and medicines for various diseases. Allowing more people around the world access to better and more potent vaccines, using cutting-edge technology that makes RNA vaccines more transportable, with broader capabilities and fewer side effects.
NeoVac revenue & valuation
| Annual revenue | $2,224,430 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $7,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
NeoVac has 13 employees across 8 departments.
Departments
Number of employees
NeoVac Tech Stack
Discover the technologies and tools that power NeoVac's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Issue trackers
Appointment scheduling
Blogs
Miscellaneous
Security
Miscellaneous
JavaScript frameworks
IaaS
CDN
Reverse proxies
Performance
France
United States
Poland
Portugal
Frequently asked questions
4.8
40,000 users
